September 25, 2016 12:44 AM ET

Pharmaceuticals

Company Overview of Purdue Pharma Inc.

Company Overview

Purdue Pharma Inc. researches, develops, and manufactures over the counter and prescription medicines for pain management, attention deficit hyperactivity, and gastrointestinal disorders for patients and healthcare professionals in Canada. Its over the counter products include laxatives, decongestant, and antiseptics for the preparation of skin prior to surgery and injections. The company’s prescription medication comprises central nervous system stimulants, opioid analgesics, opioid antagonists, and bronchodilators. It also engages in the research in the field of drug delivery for the treatment of respiratory diseases, infection control, and urinary incontinence. The company was founded in ...

575 Granite Court

Pickering, ON L1W 3W8

Canada

Founded in 1956

Phone:

905-420-6400

Fax:

905-420-6342

Key Executives for Purdue Pharma Inc.

Chief Executive Officer and President
Chief Financial Officer and Executive Vice President
Age: 51
Chief Executive Officer of Purdue Pharma L.P. and President of Purdue Pharma L.P.
Executive Vice President of Finance
Executive Vice President for Due Diligence & Integration Management
Compensation as of Fiscal Year 2016.

Purdue Pharma Inc. Key Developments

Medical Developments International Limited Signs Exclusive Licensing and Distribution Agreement with Purdue Pharma Canada for Penthrox® in Canada

Medical Developments International Limited announced that it has reached an exclusive distribution and licensing agreement with Purdue Pharma (Canada) for Penthrox® (Low-Dose Methoxyflurane) Inhaler in Canada. Purdue Canada will pay MDI up to CAD 3 million through a combination of upfront, milestone, and success basedpayments.

Helsinn Group Signs Agreement with Purdue Pharma Canada

Helsinn Group signed an agreement with Purdue Pharma Canada, for the distribution and licensing of Akynzeo. Akynzeo is the oral fixed combination of netupitant and palonosetron and is used to prevent chemotherapy-induced nausea and vomiting (CINV). As per the terms of the deal, Helsinn will continue to carry out the clinical development activities, along with the manufacturing and supply of Akynzeo. Purdue Pharma will enjoy the rights to registration, promotion, marketing, sales and distribution of Akynzeo across Canada.

John Sebben Joins Purdue Pharma Canada as Vice President, Manufacturing Operations

John Sebben has joined Purdue Pharma Canada as Vice President, Manufacturing Operations, effective April 11, 2016. John brings to Purdue more than 20 years of Canadian and International supply chain and manufacturing operations leadership experience, having worked at a number of premier companies including: GlaxoSmithKline, Apotex, Teva Canada, Pharmascience, Biovail and most recently, Patheon, where he held the role of Vice President, North American Supply Chain.

Similar Private Companies By Industry

Company Name Region
4everPets Ltd. Americas
9037136 Canada Inc. Americas
AAA Heidelberg Inc. Americas
Ab Biotech Inc. Americas
ABcann Medicinals Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Purdue Pharma Inc., please visit www.purdue.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.